SciBase completes rights issue, raising SEK 40.2 million
SciBase Holding AB announced on October 1, 2026, the outcome of its rights issue of shares. The company successfully raised approximately SEK 40.2 million, representing 69.9 percent of the total rights issue.
SciBase Holding AB announced on October 1, 2026, the results of its rights issue of shares, initially planned for approximately SEK 57.5 million. The subscription period for the issue concluded on September 29, 2026. The company reported that 2,681,085 shares were subscribed for with the support of subscription rights.
These subscriptions amounted to approximately SEK 40.2 million, fulfilling 69.9 percent of the total rights issue. An additional 133,116 shares were subscribed for without subscription rights. The board of directors had resolved to proceed with the rights issue on September 3, 2026, based on authorization from the annual general meeting on May 19, 2026.
The capital raised is intended to strengthen the company's financial position and support its ongoing development and commercialization efforts. The total subscription rate indicates a partial success in reaching the planned funding target.
SciBase continues its operations with the aim of advancing its product portfolio in the medical technology sector.